Yang et al. [40] explored how NFKBIA influences NF-κB signaling activity and inflammation associated with BRCA tumors, with their findings showing that NFKBIA functions as a suppressor of the NF-κB pathway. This evidence concerns the gene NFKB1 and invasive breast carcinoma.